FLUORINATED DERIVATIVES OF 4-AZASTEROID AS ANDROGEN RECEPTOR MODULATORS Russian patent published in 2008 - IPC C07J73/00 A61K31/473 A61K31/56 A61P5/26 

Abstract RU 2320670 C2

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention describes compound of the formula (I) or its pharmaceutically acceptable salt, or an enantiomer wherein n = 0 or 1; a - b means -CF=CH or -CHFCH2; R1 represents (C1-C3)-alkyl wherein alkyl is unsubstituted; R2 represents hydrogen atom; R3 is chosen from (C1-C4)-alkyl, (CH2)n-cycloheteroalkyl and (CH2)n-aryl; or R2 and R3 form in common 6-membered saturated ring condensed with 5-membered aromatic ring system comprising 2 heteroatoms chosen from nitrogen atom (N), and pharmaceutical compositions. Compounds of the formula (I) represent modulators of androgen receptors (AR) possessing tissue-selective effect. Proposed compounds are useful as androgen receptors agonists in osseous and/or muscle tissue in antagonizing AR in male patient prostate or in female patient uterus.

EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.

36 cl, 2 tbl, 72 ex

Similar patents RU2320670C2

Title Year Author Number
FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION 1993
  • Akille Pantseri
  • Marchella Nesi
  • Ehnriko Di Salle
RU2125061C1
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE 1992
  • Glenn Dzh.Gomlej
  • Ehlizabet Stoner
RU2125879C1
ANDROSTEN(ANE) (ONE) DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF, METHODS OF PREPARATION THEREOF, AND METHOD OF MEDICAL TREATMENT 1994
  • Behchelor Kennet Uil'Jam
  • Fraj Stiven Vernon
RU2144037C1
METHODS OF SYNTHESIS OF AZASTEROID DERIVATIVES, DERIVATIVE OF AZASTEROID-IMIDAZOLIDE, METHOD OF ITS SYNTHESIS 1998
  • Pantseri Akille
  • D'Anello Matteo
  • Longo Antonio
  • Nesi Marchella
RU2198176C2
INHIBITORS OF TESTOSTERONE 5α-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TESTOSTERONE 5α-REDUCTASE ACTIVITY 1993
  • Fernand Labri
  • Iv Meran
  • Shankar M.Singkh
RU2141967C1
HALOGEN- AND PSEUDOHALOGEN-SUBSTITUTED 17-METHYLENE-4-AZASTEROIDS, THEIR USING, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION 2002
  • Mentsenbakh Bernd
  • Dresher Peter
  • Khillish Aleksander
  • Ehl'Ger Val'Ter
  • Shvajkert Khans-Udo
  • Shell'Kopf Klaus
RU2293740C2
SPECIFIC GLYCOCOTRICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT 2004
  • Biggadajk Kejt
  • Dzhon Meht'Ju Piter
  • Nidkham Debora
RU2348645C2
ANTIANDROGENIC COMPOUNDS, PRECURSOR OF ANTIANDROGENIC COMPOUND, PHARMACEUTICAL COMPOSITIONS 1993
  • Fernand Labri
  • Iv Merand
  • Shankar M.Singkh
RU2141966C1
16α-BROMO-3β-HYDROXY-5α-ANDROSTANE-17-ONE SEMIHYDRATE, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITIONS, USING COMPOUNDS 2000
  • Alem Klarens Nataniehl
  • Frinke Dzhejms Martin
  • De Karval'O Luis Daniehl' Dos Ankhos
  • Khehggi Vil'Jam
  • Prendergast Patrik T.
  • Riding Kristofer L.
  • Tadikonda Krupakar Pol
  • Vernon Rassehl' Nehjl
RU2295534C2
COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF PROSTATE CANCER 1998
  • Kodzima Koiti
  • Kobajasi Tomovo
RU2196582C2

RU 2 320 670 C2

Authors

Mejssner Robert S.

Perkins Dzhejms Dzh.

Dates

2008-03-27Published

2003-03-07Filed